Conduct Preclinical Combination Studies: Before considering any human trials for a mots c retatrutide stack, extensive in vitro and in vivo studies in animal models are essential to evaluate potential synergies, interactions, and safety
Copper(II)-glycyl-L-histidyl-L-lysine MOLECULAR FORMULA C 28 H 46 CuN 12 O 8 MOLECULAR WEIGHT 742.3 g/mol STRUCTURE Linear tripeptide PEPTIDE SEQUENCE Gly-His-Lys CHEMICAL STRUCTURE CAS Number: 300801-03-0 Molecular Formula : C 28 H 46 CuN 12 O 8 Source: PubChem Mechanism of Action GHK-Cu acts primarily by delivering bioavailable copper(II) to tissues and cells and modulating a range of biological pathways associated with repair and regeneration
its rapidly depleted by constant illness, inflammation, and stress
Compound 4 (1.94 g, 2.47 mmol), H-Lys-OMe2HCl (0.24 g, 1.03 mmol), PYBOP (1.62 g, 3.10 mmol) and HOBT (0.42 g, 3.10 mmol) were dissolved in DMF (40 mL) under nitrogen atmosphere and ice bath conditions